Valuation: DiaSorin S.p.A.

Market Cap 3.59B 4.1B 3.31B 3.09B 5.82B 388B 5.93B 39.76B 15.43B 191B 15.41B 15.06B 667B P/E 2026 *
19.7x
P/E 2027 * 17.2x
Enterprise Value 4.27B 4.87B 3.94B 3.67B 6.91B 461B 7.04B 47.23B 18.33B 227B 18.3B 17.89B 792B EV / Sales 2026 *
3.48x
EV / Sales 2027 * 3.16x
Free-Float
-
Yield 2026 *
1.93%
Yield 2027 * 2.01%
1 day-3.14%
1 week+3.51%
Current month+1.86%
1 month+1.86%
3 months+16.31%
6 months-1.25%
Current year-1.25%
1 week 64.56
Extreme 64.56
70.26
1 month 62.96
Extreme 62.96
75.3
Current year 52.34
Extreme 52.34
77.64
1 year 52.34
Extreme 52.34
92.32
3 years 52.34
Extreme 52.34
112.35
5 years 52.34
Extreme 52.34
208.8
10 years 49.98
Extreme 49.98
211.8
Manager TitleAgeSince
Chief Executive Officer 60 2007-03-25
Director of Finance/CFO - 2024-12-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 60 2016-04-27
Director/Board Member 63 2007-03-25
Chairman 57 2022-04-28
Date Insider Type Main position Quantity % Market Cap.
03-23Buy

Chief Executive Officer

9,211 0.0165%
01-27Buy

Chief Executive Officer

7,500 0.0134%
01-07Buy

Director

700 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
-3.14%+3.51%-26.38%-26.86% 4.23B
-2.41%+16.46%+194.99%+313.42% 20.39B
-1.65%+2.08%-42.27%-27.84% 9.41B
+1.24%+4.46%+36.14%+33.74% 7.13B
-2.73%+2.95%-33.53% - 5.18B
-2.33%-1.18%-24.99%-28.43% 4.97B
+3.20%+16.39%+226.85%-32.38% 4.72B
+5.76%-3.02%+96.33%+102.81% 4.11B
-2.94%-3.88%-22.30%-43.68% 2.51B
-1.24%-1.13%-37.81%-57.57% 1.24B
Average -0.62%+5.37%+36.70%+25.91% 6.39B
Weighted average by Cap. -1.02%+9.15%+74.95%+105.64%

Financials

2026 *2027 *
Net sales 1.23B 1.4B 1.13B 1.06B 1.99B 133B 2.03B 13.58B 5.27B 65.39B 5.26B 5.14B 228B 1.31B 1.49B 1.21B 1.13B 2.12B 141B 2.16B 14.47B 5.61B 69.64B 5.61B 5.48B 243B
Net income 183M 209M 169M 157M 296M 19.76B 302M 2.02B 785M 9.74B 784M 766M 33.93B 206M 236M 190M 178M 334M 22.31B 341M 2.28B 886M 11B 885M 865M 38.3B
Net Debt 674M 770M 622M 581M 1.09B 72.89B 1.11B 7.46B 2.9B 35.93B 2.89B 2.83B 125B 543M 620M 501M 468M 880M 58.72B 896M 6.01B 2.33B 28.94B 2.33B 2.28B 101B
Logo DiaSorin S.p.A.
DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2025, the group had 9 production sites located in Italy, the United States (4), Canada, Germany, the United Kingdom and Chine. Net sales are distributed geographically as follows: Italy (15.2%), Europe (24.9%), North America (51.8%), and other (8.1%).
Employees
3,242
Date Price Change Volume
26-06-30 €67.76 -3.14% 238,260
26-06-29 €69.96 +2.37% 331,777
26-06-26 €68.34 +2.92% 208,577
26-06-25 €66.40 -0.12% 239,419
26-06-24 €66.48 +3.13% 223,750
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
67.76EUR
Average target price
70.52EUR
Spread / Average Target
+4.08%

Quarterly revenue - Rate of surprise